NOVA PHARMACEUTICAL INC
10QSB, EX-27, 2000-11-14
PHARMACEUTICAL PREPARATIONS
Previous: NOVA PHARMACEUTICAL INC, 10QSB, 2000-11-14
Next: E PIPHANY INC, 10-Q, 2000-11-14



<TABLE> <S> <C>

<ARTICLE>   5

    <S>                                             <C>
<PERIOD-TYPE>                                       9-MOS
<FISCAL-YEAR-END>                                DEC-31-2000
<PERIOD-END>                                     SEP-30-2000
<CASH>                                                  0
<SECURITIES>                                            0
<RECEIVABLES>                                      51,362
<ALLOWANCES>                                            0
<INVENTORY>                                       109,387
<CURRENT-ASSETS>                                  880,276
<PP&E>                                             37,949
<DEPRECIATION>                                          0
<TOTAL-ASSETS>                                  1,789,112
<CURRENT-LIABILITIES>                           1,288,447
<BONDS>                                                 0
<COMMON>                                           23,208
                                   0
                                             0
<OTHER-SE>                                        401,042
<TOTAL-LIABILITY-AND-EQUITY>                    1,789,112
<SALES>                                           173,454
<TOTAL-REVENUES>                                  173,454
<CGS>                                             112,271
<TOTAL-COSTS>                                      61,183
<OTHER-EXPENSES>                                3,369,285
<LOSS-PROVISION>                                        0
<INTEREST-EXPENSE>                                788,728
<INCOME-PRETAX>                                (4,713,560)
<INCOME-TAX>                                            0
<INCOME-CONTINUING>                            (4,713,560)
<DISCONTINUED>                                          0
<EXTRAORDINARY>                                         0
<CHANGES>                                               0
<NET-INCOME>                                   (4,713,560)
<EPS-BASIC>                                        (.28)
<EPS-DILUTED>                                        (.28)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission